- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scilex Holding Co (SCLX)
Scilex Holding Co stock price live, this page displays NASDAQ SCLX stock exchange data. View the SCLX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scilex Holding Co real time stock price chart below.
What Is the Scilex Holding Co Stock Price Today?
The Scilex Holding Co stock price today is 13.990.
What Is the Stock Symbol for Scilex Holding Co?
The stock symbol for Scilex Holding Co is ""SCLX.""
What Stock Exchange Does Scilex Holding Co Trade On?
Scilex Holding Co is listed and trades on the NASDAQ stock exchange.
Is Scilex Holding Co a Good Stock to Buy?
Determining whether Scilex Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLX quote. (ISIN: US80880W2052)
What Is the Scilex Holding Co Stock Price Today?
The Scilex Holding Co stock price today is 13.990.
What Is the Stock Symbol for Scilex Holding Co?
The stock symbol for Scilex Holding Co is ""SCLX.""
What Stock Exchange Does Scilex Holding Co Trade On?
Scilex Holding Co is listed and trades on the NASDAQ stock exchange.
Is Scilex Holding Co a Good Stock to Buy?
Determining whether Scilex Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLX quote. (ISIN: US80880W2052)
NASDAQ
Currency in USD
13.990
-0.970(-6.48%)
Closed·
After Hours
14.200+0.210(+1.50%)
·
Fair Value
An estimate of a Scilex Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.670
14.805
52 wk Range
3.600
50.400
SCLX Scorecard
Full Analysis
High shareholder yield
SCLX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Scilex Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.67014.805
52 wk Range
3.60050.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SCLX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Scilex Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K Scilex Holding Co For: 23 July
- Investing.com
- Form 8K Scilex Holding Co For: 23 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Scilex Holding Co Company Profile
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.
Compare SCLX to Peers and Sector
Metrics to compare | SCLX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −1.3x | −0.5x | |
PEG Ratio | −0.02 | 0.01 | 0.00 | |
Price/Book | −0.4x | 0.9x | 2.6x | |
Price / LTM Sales | 1.6x | 1.8x | 3.3x | |
Upside (Analyst Target) | - | 83.4% | 43.5% | |
Fair Value Upside | Unlock | 6.8% | 6.3% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-2.26 / -0.12
Revenue / Forecast
5.00M / 28.50M
People Also Watch
FAQ
What Stock Exchange Does Scilex Holding Trade On?
Scilex Holding is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Scilex Holding?
The stock symbol for Scilex Holding is "SCLX."
What Is the Scilex Holding Market Cap?
As of today, Scilex Holding market cap is 76.91M.
What Is Scilex Holding's Earnings Per Share (TTM)?
The Scilex Holding EPS (TTM) is -12.61.
From a Technical Analysis Perspective, Is SCLX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Scilex Holding Stock Split?
Scilex Holding has split 1 times.
How Many Employees Does Scilex Holding Have?
Scilex Holding has 111 employees.
What is the current trading status of Scilex Holding (SCLX)?
As of 05 Aug 2025, Scilex Holding (SCLX) is trading at a price of 13.99, with a previous close of 14.96. The stock has fluctuated within a day range of 13.67 to 14.81, while its 52-week range spans from 3.60 to 50.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.